Lately, we hear many questions from patients about the COVID-19 vaccine and fertility and impact on pregnancy.
Vios Fertility Institute follows the guidelines from both the American Society for Reproductive Medicine (ASRM) and The American College of Obstetricians and Gynecologists (ACOG) in recommending that pregnant women, and women seeking to become pregnant, get the vaccine as it becomes available. These guidelines are constantly adjusted as new data is available and our team will continue to stay on top of the changes.
What else do you need to know about the COVID-19 vaccine and its impact on fertility?
- Both the Pfizer and Moderna vaccines are messenger ribonucleic acid (mRNA)-based and therefore do not contain the live virus. This means that the vaccine elicits an immune response so if the recipient were to get COVID-19 she would have some immunity over it.
- The vaccine does NOT appear to interfere with fertility in men or women.
Dr. MacKenzie Purdy and Dr. Roohi Jeelani answered many questions on this topic during our Instagram Live this week. Click below to watch!
View this post on Instagram
Vios Fertility Institute is proud to partner with the University of California-San Francisco to make patients aware of the ASPIRE study regarding COVID19 and pregnancy. ASPIRE stands for Assessing Safety of Pregnancy In the Coronavirus Pandemic.
ASPIRE is a nationwide prospective cohort study of pregnant women and their offspring during the COVID-19 pandemic. All Society for Assisted Reproductive Technology (SART) member clinics have been invited to share this study information with their pregnant patients, directing patients to register to participate at this website.
From ASPIRE, “The goal of this study is to help understand the spread of COVID-19 infection among pregnant women and how infection might affect the health and wellbeing of pregnant mothers and their babies, particularly when the infection occurs in early pregnancy or without any symptoms. The goal is for this knowledge to inform and empower pregnant women and their healthcare providers to provide the best possible care for their pregnancies and future babies. Also, women and couples planning pregnancies will gain important information to help make decisions for their families.”
ASPIRE is focused on the first trimester, a critical and vulnerable period when all of a baby’s organ systems form and the placenta – the crucial connection between mom and baby – develops.
Currently, there are no data about the effects of COVID19 infections in the first trimester. The ASPIRE study will provide critical information to:
(1) Guide the care of pregnant women
(2) Protect the safety of their babies and families
(3) Help those considering pregnancy in the future understand what it means to be pregnant in this new era
Becoming pregnant at any time is a personal choice and with the added uncertainty of a global pandemic, we realize this decision did not come lightly. We celebrate your pregnancy!
We’re also careful to counsel our patients at every step of their care journey about COVID19 and pregnancy considerations and safety guidelines so that you can feel informed and an active and empowered partner in your care.
Who can join the ASPIRE Study?
Anyone who is over the age of 18 and is between 4 – 10 weeks pregnant. Eligible participants will be compensated financially.
- You’ll be asked to:
1. Submit frequent, quick (<1 minute each) symptom tracking reports using your mobile phone and/or computer.
- 2. Collect finger-stick blood samples from home at several points throughout your pregnancy. (A helpful how to video is here.)
- 3. Give permission to review medical records related to your pregnancy, delivery and baby’s development.
- 4. Complete questionnaires online about your health during your pregnancy and after delivery of your baby.
How to get started:
Visit https://aspire.ucsf.edu/ to learn more and register on their website here.
Do you have additional questions about COVID-19 and fertility treatment at Vios? Click here for our latest update.